Noticias y vídeos - NEVRO CORP.

Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024 PR Newswire REDWOOD CITY, Calif., April 17, 2024 REDWOOD CITY, Calif. , April 17, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the first quarter of 2024 after the market closes on Tuesday, May 7, 2024 . The company...

Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw PR Newswire REDWOOD CITY, Calif., Feb. 28, 2024 Nevro1™ Proven to Immediately Transfix Sacroiliac (SI) Joint to Allow for Long-term SI Joint Fusion REDWOOD CITY, Calif. , Feb. 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that the U.S. Food and Drug...

Nevro Enters Into Cooperation Agreement With Engaged Capital PR Newswire REDWOOD CITY, Calif., Feb. 21, 2024 Appoints Kirt P. Karros to Board of Directors REDWOOD CITY, Calif. , Feb. 21, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has entered into a Cooperation Agreement with Engaged Capital, LLC ("Engaged Capital"), pursuant to which Kirt P....

Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results PR Newswire REDWOOD CITY, Calif., Feb. 21, 2024 Provides Full-Year and First-Quarter 2024 Guidance REDWOOD CITY, Calif. , Feb. 21, 2024 /PRNewswire/ --Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its fourth-quarter and full-year 2023 financial results. The company also provided first-quarter and full-year 2024...

Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy PR Newswire REDWOOD CITY, Calif., Feb. 1, 2024 Experts in diabetes, pain and health services from the Worldwide Initiative for Diabetes Education recommend spinal cord stimulation when symptoms aren't responsive to first- or second-line therapies REDWOOD CITY, Calif. , Feb. 1, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device...

Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024 PR Newswire REDWOOD CITY, Calif., Jan. 29, 2024 REDWOOD CITY, Calif. , Jan. 29, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that the company will release its financial results for the fourth quarter and full year ended December 31, 2023 after...

Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy PR Newswire REDWOOD CITY, Calif., Jan. 18, 2024 Spinal Cord Stimulation Coverage Policy to Include 43 Million Additional Covered Lives REDWOOD CITY, Calif. , Jan. 18, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Carelon Healthcare , a...

Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting PR Newswire REDWOOD CITY, Calif., Jan. 17, 2024 Presentations review clinical results of 10 kHz Therapy™ for the treatment of chronic back and leg pain, non-surgical back pain (NSBP), and painful diabetic neuropathy (PDN) REDWOOD CITY, Calif. , Jan. 17, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for...

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results PR Newswire REDWOOD CITY, Calif., Jan. 9, 2024 Fourth-Quarter 2023 Worldwide Revenue Exceeds Company's Expectations Announces Restructuring to Support Company's Long-Term Growth and Profitability REDWOOD CITY, Calif. , Jan. 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced its...

Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire REDWOOD CITY, Calif., Jan. 4, 2024 REDWOOD CITY, Calif. , Jan. 4, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that members of its management team will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 . The company's formal...

Nevro Announces Acquisition of Vyrsa™ Technologies PR Newswire REDWOOD CITY, Calif., Nov. 30, 2023 Refinances with $200M Structured Debt Maturing in 2029 REDWOOD CITY, Calif. , Nov. 30, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has acquired Vyrsa Technologies ("Vyrsa"), a privately held medical technology company focused on a minimally...

Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain PR Newswire REDWOOD CITY, Calif., Nov. 20, 2023 Data Published in Journal of Neurosurgery: Spine Highlight Lasting Pain Relief, Enhanced Function, Quality of Life, and Reduced Opioid Dependency with High-Frequency SCS Therapy REDWOOD CITY, Calif. , Nov. 20, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company...

Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance PR Newswire REDWOOD CITY, Calif., Nov. 1, 2023 REDWOOD CITY, Calif. , Nov. 1, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its third quarter 2023 financial results. The Company also provided fourth quarter guidance and updated its...

Nevro to Report Third Quarter 2023 Financial Results PR Newswire REDWOOD CITY, Calif., Oct. 4, 2023 Company to Host Conference Call on Wednesday, November 1, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif. , Oct. 4, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that the company will report its financial results for the third quarter ended September...

New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy PR Newswire REDWOOD CITY, Calif., Sept. 18, 2023 Publications Show Reductions in Hospital Resource Utilization Associated with 10 kHz Therapy Spinal Cord Stimulation for the Treatment of Painful Diabetic Neuropathy and Nonsurgical Refractory Back Pain REDWOOD CITY, Calif. , Sept. 18, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering...

Nevro Announces Participation in Upcoming Investor Conferences PR Newswire REDWOOD CITY, Calif., Aug. 23, 2023 REDWOOD CITY, Calif. , Aug. 23, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced today that it is participating in the following investor conferences: On September 7, 2023 , Kevin Thornal , Chief Executive Officer and President, and Rod MacLeod , Chief Financial...

Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance PR Newswire REDWOOD CITY, Calif., Aug. 1, 2023 Company Takes Proactive Steps to Improve Commercial Execution and Maximize Growth Opportunities REDWOOD CITY, Calif. , Aug. 1, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its second quarter...

Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference PR Newswire REDWOOD CITY, Calif., July 13, 2023 Abstract Presentations Highlight Durable Pain Relief and Improved Quality of Life for Patients Receiving 10 kHz Spinal Cord Stimulation Therapy for Painful Diabetic Neuropathy and Non-Surgical Back Pain Symposium on the Future of SCS and How AI Technology Can Improve Outcomes with HFX iQ™ REDWOOD CITY, Calif. , July 13, 2023 /PRNewswire/ -- Nevro...

Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference PR Newswire REDWOOD CITY, Calif., July 12, 2023 Wednesday, August 9, 2023 at 8:30 am Eastern Time REDWOOD CITY, Calif. , July 12, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Kevin Thornal , Nevro's CEO and President, and Rod MacLeod , Nevro's CFO, will present at the Canaccord...

Nevro to Report Second Quarter 2023 Financial Results PR Newswire REDWOOD CITY, Calif., June 27, 2023 Company to Host Conference Call on Tuesday, August 1, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif. , June 27, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that the company will report its financial results for the second quarter ended June 30,...